Evidence map›Paper›PMID 26259814›Full record

ArticleInfection and immunity2015

Primary Structural Variation in Anaplasma marginale Msp2 Efficiently Generates Immune Escape Variants.

Telmo Graça, Lydia Paradiso, Shira L Broschat, Susan M Noh, Guy H Palmer

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Adaptation ofmSphere · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Segmental Variation in a DuplicatedInfection and immunity · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Telmo GraçaThe Paul G. Allen School for Global Animal Health, Washington State University, Pullman, Washington, USA Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, Washington, USA telmo@vetmed.wsu.edu.
Lydia ParadisoThe Paul G. Allen School for Global Animal Health, Washington State University, Pullman, Washington, USA School of Electrical Engineering and Computer Science, Washington State University, Pullman, Washington, USA.
Shira L BroschatThe Paul G. Allen School for Global Animal Health, Washington State University, Pullman, Washington, USA Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, Washington, USA School of Electrical Engineering and Computer Science, Washington State University, Pullman, Washington, USA.
Susan M NohThe Paul G. Allen School for Global Animal Health, Washington State University, Pullman, Washington, USA Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, Washington, USA Animal Disease Research Unit, Agricultural Research Service, U.S. Department of Agriculture, Pullman, Washington, USA.
Guy H PalmerThe Paul G. Allen School for Global Animal Health, Washington State University, Pullman, Washington, USA Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, Washington, USA School of Electrical Engineering and Computer Science, Washington State University, Pullman, Washington, USA.
Washington State University · US

Funding

Antigenic variation in microbial transmissionR37AI044005 · NIAID · WASHINGTON STATE UNIVERSITY · PI PALMER, GUY HUGHES · 2009 to 2018
$3.3M
NIAID NIH HHS R37 AI044005NIAID NIH HHS R37 AI44005
6 · The paper itself

Abstract

Antigenic variation allows microbial pathogens to evade immune clearance and establish persistent infection. Anaplasma marginale utilizes gene conversion of a repertoire of silent msp2 alleles into a single active expression site to encode unique Msp2 variants. As the genomic complement of msp2 alleles alone is insufficient to generate the number of variants required for persistence, A. marginale uses segmental gene conversion, in which oligonucleotide segments from multiple alleles are recombined into the expression site to generate a novel msp2 mosaic not represented elsewhere in the genome. Whether these segmental changes are sufficient to evade a broad antibody response is unknown. We addressed this question by identifying Msp2 variants that differed in primary structure within the immunogenic hypervariable region microdomains and tested whether they represented true antigenic variants. The minimal primary structural difference between variants was a single amino acid resulting from a codon insertion, and overall, the amino acid identity among paired microdomains ranged from 18 to 92%. Collectively, 89% of the expressed structural variants were also antigenic variants across all biological replicates, independent of a specific host major histocompatibility complex haplotype. Biological relevance is supported by the following: (i) all structural variants were expressed during infection of a natural host, (ii) the structural variation observed in the microdomains corresponded to the mean length of variants generated by segmental gene conversion, and (iii) antigenic variants were identified using a broad antibody response that developed during infection of a natural host. The findings demonstrate that segmental gene conversion efficiently generates Msp2 antigenic variants.

Indexed as

Antigenic VariationAmino Acid SequenceAnaplasma marginaleAnaplasmosisAntibodies, BacterialAntigens, BacterialBacterial Outer Membrane ProteinsHumansImmune EvasionMolecular Sequence DataProtein Structure, TertiarySequence AlignmentAntibodies, BacterialAntigens, BacterialBacterial Outer Membrane Proteinsp44 protein, Anaplasma phagocytophila

Identifiers

PMID26259814
PMCPMC4598416
OpenAlexW2280558609

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.